[How to treat a localized prostate cancer: irradiation, surgery or watchful waiting?]

Related Experiment Video

Updated: Aug 15, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

T Zellweger1, T Gasser

  • 1Urologische Universitätskliniken beider Basel, Kantonsspital Liestal.

Praxis
|September 21, 2005
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Aug 15, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Articles linked to this work by shared authors, journal, and citation graph.

Reduced Complexity Model Intercomparison Project Phase 2: Synthesizing Earth System Knowledge for Probabilistic Climate Projections.

Earth's future·2021

Integrated molecular landscape of Parkinson's disease.

NPJ Parkinson's disease·2017

[Stereotactic laser thermocoagulation in epilepsy surgery].

Der Nervenarzt·2017

Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.

European journal of neurology·2017

Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.

Neurobiology of aging·2016

GBA-associated parkinsonism and dementia: beyond α-synucleinopathies?

European journal of neurology·2015

[Autumn vaccinations for older adults: Influenza, Covid-19 and respiratory syncytial virus (RSV)].

Praxis·2026

[Practice-oriented overview - current state of rhinosinusitis in adults based on the latest consensus papers and publications].

Praxis·2026

[Latent ureteric outlet stenosis in young adults - the diagnostic significance of functional assessment in cases of marked hydronephrosis].

Praxis·2026

[Somatic symptoms in cases of psychiatric comorbidity - an interdisciplinary care approach].

Praxis·2026

[10 Things Cardiologists Need to Know About Cardiac Amyloidosis].

Praxis·2026

[Exertional dyspnea in the elderly - interpretation of an incidental finding].

Praxis·2026

A cell-type resolved proton RBE model for potential clinical application.

Medical physics·2026

Three-fraction preoperative stereotactic radiotherapy for resectable brain metastases: the phase 2 STEP trial.

Neuro-oncology·2026

Adaptive MR-guided whole-pelvic SBRT with or without focal intraprostatic lesion boost for high-risk localized prostate Cancer: Adverse events and longitudinal quality-of-life outcomes.

Clinical and translational radiation oncology·2026

Development and validation of a cumulative risk model and assessment tool for radiation-induced hypothyroidism in head and neck cancer: a multicentre study.

Clinical and translational radiation oncology·2026

Radiation therapy quality assurance (RT QA) of adjuvant fractionated radiotherapy for WHO grade 2 atypical meningioma in the ROAM/EORTC1308 trial.

Clinical and translational radiation oncology·2026

Radiotherapy-induced oxidative stress and mitochondrial dysfunction: potential contributions of toxic elements and associated biomarkers-a systematic review.

Frontiers in public health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us